compare glp 1 agonists Meta-analysis comparing effects of short-and long-acting GLP-1 receptor GLP-1 RECEPTORS AGONISTS Comparisons among
Description
GLP-1RAs showed significantly more reduction of cardiovascular endpoints than other second- or third-line glucose-lowering medications
With regard to adverse effects, gastrointestinal intoleranceespecially nausea and vomitingrepresents the class-defining limitation
Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas
They have been optimized by millions of years of evolution to disrupt specific physiological processesprecisely the characteristics sought in drug development
[DOI] [PubMed] [Google Scholar] 37.Singh S, et al
